Effects of hypertrophic cardiomyopathy mutations in troponin I on contractility of skinned cardiac muscle fibres

Effects of hypertrophic cardiomyopathy mutations in troponin I on contractility of skinned cardiac muscle fibres

Dettagli Bibliografici
Autori principali:	Burton, D, Redwood, C, Watkins, H, Ashley, C
Natura:	Journal article
Pubblicazione:	2002

Documenti analoghi

Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility.
di: Burton, D, et al.
Pubblicazione: (2002)

Two mutations in human cardiac troponin I known to cause hypertrophic cardiomyopathy have different effects on cardiac muscle contraction
di: Burton, D, et al.
Pubblicazione: (2000)

Investigation of troponin I mutations causing familial hypertrophic cardiomyopathy
di: Abdulrazzak, H, et al.
Pubblicazione: (2001)

Altered inhibitory and troponin C-binding activities in cardiac troponin I mutants known to cause hypertrophic cardiomyopathy
di: Elliott, K, et al.
Pubblicazione: (2000)

Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy.
di: Elliott, K, et al.
Pubblicazione: (2000)

Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
di: Robinson, P, et al.
Pubblicazione: (2007)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
di: Robinson, P, et al.
Pubblicazione: (2002)

A troponin I mutant known to cause hypertrophic cardiomyopathy shows reduced inhibition of Ca2+ independent tension
di: Burton, D, et al.
Pubblicazione: (2000)

Mutations in fast skeletal troponin I, troponin T, and beta-tropomyosin that cause distal arthrogryposis all increase contractile function.
di: Robinson, P, et al.
Pubblicazione: (2007)

Hypertrophic Cardiomyopathy Cardiac Troponin C Mutations Differentially Affect Slow Skeletal and Cardiac Muscle Regulation
di: Jose R. Pinto, et al.
Pubblicazione: (2017-04-01)

Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha -tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay.
di: Bing, W, et al.
Pubblicazione: (2000)

Investigating the Effect of Cardiomyopathy-Causing Mutations in Cardiac Troponin-T on Calcium Buffering In Situ
di: Robinson, P, et al.
Pubblicazione: (2010)

The effect of HCM mutations in troponin T and troponin I on the calcium binding of human cardiac troponin
di: Redwood, C, et al.
Pubblicazione: (2001)

Hypertrophic Cardiomyopathy Mutations of Troponin Reveal Details of Striated Muscle Regulation
di: J. M. Chalovich, et al.
Pubblicazione: (2022-05-01)

Functional effects of the DCM mutant Gly159Asp troponin C in skinned muscle fibres.
di: Preston, L, et al.
Pubblicazione: (2007)

Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy.
di: Robinson, P, et al.
Pubblicazione: (2002)

Mechanical effects of human cardiac troponin C mutation Gly159Asp in exchanged rabbit psoas fibres
di: Preston, L, et al.
Pubblicazione: (2004)

Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca2+-sensitivity and suppress the modulation of Ca2+-sensitivity by troponin I phosphorylation
di: Messer, A, et al.
Pubblicazione: (2016)

Dilated cardiomyopathy causing mutations in cardiac troponin T (TNT), cardiac troponin C (TNC), and alpha tropomyosin (TM) reduce CA(2+) sensitivity and maximum calcium activation
di: Redwood, C, et al.
Pubblicazione: (2004)

Assessment of dynamic cardiac repolarization and contractility in patients with hypertrophic cardiomyopathy.
di: Andrew E Radbill, et al.
Pubblicazione: (2021-01-01)

Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy.
di: Mogensen, J, et al.
Pubblicazione: (2004)

Hypertrophic and dilated cardiomyopathycausing mutations of troponin and alpha-tropomyosin have opposite effects on thin filament calcium binding
di: Robinson, P, et al.
Pubblicazione: (2007)

An in silico analysis of troponin I mutations in hypertrophic cardiomyopathy of Indian origin.
di: Gayatri Ramachandran, et al.
Pubblicazione: (2013-01-01)

Functional effects of mutations in troponin T and tropomyosin which cause dilated cardiomyopathy
di: Robinson, P, et al.
Pubblicazione: (2003)

Using fluorescence emission spectroscopy to asses the Ca2+ affinity of reconstituted troponin and thin filaments containing cardiomyopathy causing mutations of troponin and alpha-tropomyosin
di: Robinson, P, et al.
Pubblicazione: (2007)

Effects of Aficamten on cardiac contractility in a feline translational model of hypertrophic cardiomyopathy
di: Ashley N. Sharpe, et al.
Pubblicazione: (2023-01-01)

Structure-function relationships of eight mutations in troponin and tropomyosin that cause dilated cardiomyopathy
di: Mirza, M, et al.
Pubblicazione: (2004)

Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T.
di: Bayliss, C, et al.
Pubblicazione: (2013)

A revised method of troponin exchange in permeabilised cardiac trabeculae using vanadate: functional consequences of a HCM-causing mutation in troponin I.
di: Preston, L, et al.
Pubblicazione: (2006)

Abnormally high values of cardiac troponin i in hypertrophic cardiomyopathy and diastolic heart failure
di: Lazić S., et al.
Pubblicazione: (2014-01-01)

Cardiac troponin and tropomyosin: structural and cellular perspectives to unveil the Hypertrophic Cardiomyopathy phenotype
di: Mayra de A. Marques, et al.
Pubblicazione: (2016-09-01)

Elevation of high‐sensitivity cardiac troponin T and left ventricular remodelling in hypertrophic cardiomyopathy
di: Toru Kubo, et al.
Pubblicazione: (2020-12-01)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
di: Blair, E, et al.
Pubblicazione: (2003)

Identification and functional analysis of cardiac troponin I as a novel disease gene in autosomal dominant familial dilated cardiomyopathy
di: Carballo, S, et al.
Pubblicazione: (2006)

Familial hypertrophic cardiomyopathy related cardiac troponin C L29Q mutation alters length-dependent activation and functional effects of phosphomimetic troponin I*.
di: Alison Y Li, et al.
Pubblicazione: (2013-01-01)

Functional analysis of hypertrophic cardiomyopathy missense mutations in the light meromyosin region of beta myosin heavy chain
di: Redwood, C, et al.
Pubblicazione: (2003)

AMP-Activated Protein Kinase Phosphorylates Cardiac Troponin I and Alters Contractility of Murine Ventricular Myocytes
di: Oliveira, S, et al.
Pubblicazione: (2012)

AMP-Activated protein kinase phosphorylates cardiac troponin i and alters contractility of murine ventricular myocytes
di: Oliveira, S, et al.
Pubblicazione: (2012)

AMP-activated protein kinase phosphorylates cardiac troponin I and alters contractility of murine ventricular myocytes.
di: Oliveira, S, et al.
Pubblicazione: (2012)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
di: Ashrafian, H, et al.
Pubblicazione: (2003)